Eminence Capital, LP Charles River Laboratories International, Inc. Transaction History
Eminence Capital, LP
- $5.69 Billion
- Q4 2024
A detailed history of Eminence Capital, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Eminence Capital, LP holds 627,472 shares of CRL stock, worth $66.5 Million. This represents 2.04% of its overall portfolio holdings.
Number of Shares
627,472
Previous 1,003,472
37.47%
Holding current value
$66.5 Million
Previous $198 Million
41.4%
% of portfolio
2.04%
Previous 2.98%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
703Shares Held
50.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$653 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$540 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$231 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$192 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$191 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $5.39B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...